Alliance Pharma plc (AIM: APH), a speciality pharmaceutical company, is pleased to announce that it has agreed to acquire Caraderm Limited ('Caraderm') More
Healthpoint Ltd. has announced that the United States Patent and Trademark Office has granted Healthpoint a Notice of Allowance on its patent application for the ointment vehicle that is the basis for Healthpoint's Xenaderm(tm). More
Foamix is partnering with leading phamaceutical companies in developing their drugs in foam formulations. The company will present at the upcoming American Academy of Dermatology meeting in New Orleans on February 18-22, 2005 More
Acrux appoints Ms Carla Gervasio Nugent as the Chief Executive Officer of its investee company Cosmeceutic Solutions. The company was set up earlier this year to develop novel skin care products for the global cosmetic markets. More
Healthpoint Ltd. has announced that the United States Patent and Trademark Office has granted Healthpoint a Notice of Allowance on its patent application for the ointment vehicle that is the basis for Healthpoint's Xenaderm(tm). More